Answer
The most common adverse reactions in Evrysdi (risdiplam) clinical studies in patients with infantile-onset spinal muscular atrophy were pyrexia (54.8%), rash (29.0%) and diarrhoea (19.4%).
Sources for this answer
- Evrysdi 0.75 mg/mL powder for oral solutionRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 12Document updated
Sources checked